Enfortumab vedotin and pembrolizumab with surgery significantly improve outcomes in cisplatin-ineligible MIBC patients, ...

For patients with darker skin tones, colorblind energy-based devices and longer-wavelength lasers are considered safest, according to Arielle Kauvar, MD, director of New York Laser & Skin Care and ...

Kelley: The HLAA is raising awareness that hearing is an important part of overall health and well-being, and it should be tested regularly and treated quickly if there’s a problem. There’s no such ...

Managed care organizations (MCOs), situated at the intersection of payers, providers, and patients, are uniquely placed to address these dual gaps. This article outlines 10 leadership priorities—5 ...

Self-administration of rozanolixizumab, a neonatal Fc receptor blocker (FcRn) indicated for generalized myasthenia gravis, ...

Researchers identify FGFR4, FLT1, and WNT5A as key biomarkers and suggest dovitinib and nintedanib as new targeted therapies ...

Neurological diseases now affect nearly half the world’s population, prompting global recognition and innovation as multiple ...

SGLT2 inhibitors may worsen heart failure outcomes from chemotherapy, highlighting the need for further long-term studies on ...

Valenzuela told The American Journal of Managed Care® ( AJMC® ) that smart infrastructure and remote monitoring can make this ...

Zongertinib received FDA approval for HER2-mutant NSCLC, showing efficacy in first-line treatment with a 77% objective ...

Andrew Wolf, MD, discusses the growing costs, treatment advances, and geographic disparities in multiple sclerosis care.

The government should focus on keeping up the funding for HIV to continue to innovate in this space, potentially eliminating ...